Science Explorer Interactive view Map
Company · Niefern-Öschelbronn · Germany

Amryt Pharma (Germany)

amrytpharma.comROR OpenAlex
Research works
5
▼ 41% vs 2013–17
Citations
122
23.7 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
61%
world 28%

Not ranked overall: Amryt Pharma (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 3.43× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.53× its world share, 0 worksBiochemistry, Geneti…Chemistry: 3.46× its world share, 0 worksChemistryEngineering: 0.14× its world share, 0 worksEngineeringMaterials Science: 1.75× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.91× its world share, 0 worksPhysics and AstronomyMedicine: 1.39× its world share, 0 worksMedicineBusiness, Management and Accounting: 5.05× its world share, 0 worksBusiness, Management…Decision Sciences: 16.84× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.36× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Decision Sciences, 16.8×. Every wedge is a field page.

Which research topics does Amryt Pharma (Germany) publish most on?

By volume in 2022–2025: Agriculture and Agroindustry Studies, Management and Optimization Techniques, Forecasting Techniques and Applications and Skin and Cellular Biology Research.

Agriculture and Agroindustry Studies: 0 fractional worksManagement and Optimization Techniques: 0 fractional worksForecasting Techniques and Applications: 0 fractional worksSkin and Cellular Biolog…0Skin and Cellular Biology Research: 0 fractional worksOphthalmology and Eye Disorders: 0 fractional worksPhytochemistry and Bioactive Compounds: 0 fractional worksAntibiotics Pharmacokinetics and Efficacy: 0 fractional worksAnesthesia and Pain Management: 0 fractional worksAnalytical Methods in Pharmaceuticals: 0 fractional worksPituitary Gland Disorders and Treatments: 0 fractional works
General Agricultural and Biological SciencesStrategy and ManagementManagement Science and Operations ResearchCell Biology6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Agriculture and Agroindustry Studies General Agricultural and Biological Sciences 0 works
  2. 2 Management and Optimization Techniques Strategy and Management 0 works
  3. 3 Forecasting Techniques and Applications Management Science and Operations Research 0 works
  4. 4 Skin and Cellular Biology Research Cell Biology 0 works
  5. 5 Ophthalmology and Eye Disorders Pathology and Forensic Medicine 0 works
  6. 6 Phytochemistry and Bioactive Compounds Biomaterials 0 works
  7. 7 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
  8. 8 Anesthesia and Pain Management Surgery 0 works
  9. 9 Analytical Methods in Pharmaceuticals Analytical Chemistry 0 works
  10. 10 Pituitary Gland Disorders and Treatments Endocrinology, Diabetes and Metabolism 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available61.2%not open38.8%

World: 28% of research is openly available.

with international co-authors35.3%domestic only64.7%

World: 19% is written across borders.

How has Amryt Pharma (Germany)'s research output changed?

Output in 2018–2022 was 41% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Niefern-Öschelbronn

All research institutions in Niefern-Öschelbronn

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.